|
|
|
|
Existing Parkinson's Disease Drug May Fight Drug-Resistant TB
Newswise Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by...
|
|
|
Parkinson's drugs show promise in resistant TB
* Drugs could be used to fight dangerous forms of TB * Compounds already proven in humans CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U...
|
|
|
New data show high benefits of pramipexole in patients with advanced Parkinsons disease
New data presented at the Movement Disorder Societys 13th International Congress of Parkinsons Disease and Movement Disorders (MDS) further confirms the high therapeutic benefit of mirapexin (pramipexole) once-daily, extended release...
|
|
|
Existing Parkinson's disease drug may fight drug-resistant TB
Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by researchers at...
|
|
|
Existing Parkinson's Disease Drug May Fight Drug-Resistant TB
Newswise - Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by...
|
|
|
Existing Parkinson's disease drug may fight drug-resistant TB
Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by researchers at...
|
|
|
Existing Parkinson's Disease Drug May Fight Drug-Resistant TB
Newswise - Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by...
|
|
|
Existing Parkinson's disease drug may fight drug-resistant TB
Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by researchers at...
|
|
|
New Weapons in Fight Against TB?
FRIDAY, July 3 (HealthDay News) -- Extreme drug-resistant tuberculosis might someday meet its match in two drugs now used to treat Parkinson's disease, suggests a new study.Researchers, led by a team from the University of...
|
|
|
EC lifts treatment restrictions on Neupro
UCB announced that Neupro (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless...
|
|
|
TopAbstracts in Parkinson's 07/01/2009
TopAbstracts in Parkinson's are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.Over 2000 peer...
|
|
|
Understanding the cell damage associated with disorders like Alzheimer's disease
associated diseases like Alzheimer's do so much damage, but new findings by researchers at RIKEN suggest that part of the answer may lie in the structural rearrangements observed in plaque-forming proteins Although there is a 'preferred'...
|
|
|
Addex to Host R&D Day on July 16
- Allosteric modulation company Addex Pharmaceuticals (SIX: ADXN) invites investors, analysts, media and other interested parties to attend its annual R&D day on Thursday, July 16, 2009 in Geneva, Switzerland.Addex management will...
|
|
|
Addex Pharmaceuticals: Addex to Host R&D Day on July 16
Addex to Host R&D Day on July 16 SOURCE: Addex Pharmaceuticals Jul 03, 2009 06:00 ET Addex to Host R&D Day on July 16 PLAN-LES-OUATES GENEVA, SWITZERLAND--(Marketwire - July 3, 2009) - Geneva, Switzerland, 2 July 2009 - Allosteric...
|
|
|
Parkinson's Disease Alters Patient's Ability To Learn From Rewards While Treatment Affects Ability To Learn Fr
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make.The test was developed by Dr. Mark Gluck, professor of...
|
|
|
Medical research: The Parkinson's problem
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make.The test was developed by Dr. Mark Gluck, professor of...
|
|
|
Santhera's FJORD Phase IIb Study Demonstrates Efficacy of JP-1730for the Treatment of Dyskinesia in Parkinson'
- Santhera Pharmaceuticals announced positive data from its Phase IIb study (FJORD).The key finding of the trial is that JP-1730/ fipamezole reduces levodopa-induced dyskinesia in Parkinson's patients. This beneficial effect was...
|
|
|
Onglyza and Cimzia recommended by CHMP
Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee for Medicinal Products for Human Use this week.Others include UCB's Cimzia (certolizumab...
|
|
|
Onglyza and Cimzia recommended by CHMP
Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee for Medicinal Products for Human Use this week.Others include UCB's Cimzia (certolizumab...
|
|
|
Stem Cell Possibilities Energize the Market
click to enlarge Estimated R&D expenditures Stem cells are the biological building blocks that form other cells in the body.Because of their universality and ability to replace or repair damaged tissue, the therapeutic benefits are...
|
|
|
GBP4m mental health genetics centre
Genetics will be used to research illnesses such as bipolar disorder A centre which will use genetics to research mental disorders is being launched by the First Minister.The 4m Centre for Neuropsychiatric Genetics and Genomics, based at...
|
|
|
Even minute, EURsafeEUR maternal carbon monoxide exposure can damage fetal brain - UCLA
Sources of carbon monoxide include gas stoves & heaters, car exhaust, cigarette smoke A UCLA study has discovered that chronic exposure during pregnancy to miniscule levels of carbon monoxide damages the cells of the fetal brain,...
|
|
|
June 25, 2009
Sources of carbon monoxide include gas stoves & heaters, car exhaust, cigarette smoke A UCLA study has discovered that chronic exposure during pregnancy to miniscule levels of carbon monoxide damages the cells of the fetal brain,...
|
|
|
Academy Sends Congress a Solution to Fix Broken Physician Payment System
Newswise The American Academy of Neurology Professional Association has sent a letter to Congress offering a solution to fix the way physicians are reimbursed under Medicare for treating patients with severe or disabling chronic conditions,...
|
|
|
Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory?
For 21 (42%) pts, OH twice more often after tilting (20 pts) vs on standing (10 pts) OH within 3 min of tilting in 9 pts (18%); L-OH in 11 pts (55%) Of 20 pts, 10 with OH on tilting were symptomatic 10 pts with OH on standing were asymptoma...
|
